| NCT Number | NCT06391242 |
| Lead Sponsor | Canadian Cancer Trials Group |
| Conditions | Cancer Metastatic |
| Enrollment | 230 participants |
| Start Date | 2025-03-07 |
| Primary Completion | 2027-07-01 (estimated) |
| Study Completion | 2028-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-11 |